Adicet Bio Statistics
NASDAQ: ACETHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.14-0.32 (-13.01%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Adicet Bio by the numbers
Adicet Bio has a market capitalization of $20.0 million based on 9.36M shares outstanding. With trailing EPS of $-7.53, Adicet Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 59.1% below its 50-day average and 70.7% below its 200-day average.
Average daily trading volume is 271.05K shares, or about $580,047 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACET valuation vs. peer median
| Metric | ACET | Peer median | Difference |
|---|---|---|---|
| Market cap | $20.03M | $19.70M | +2% |
| Avg. volume | 271.05K | 552.17K | -51% |
Peer median across 8 companies: RNAZ, AARD, TXMD, IGC, CPHI, COCP, MRKR, CRVO.
Valuation
- Market cap
- $20.03M
- EPS (TTM)
- $-7.53
- Shares outstanding
- 9.36M
Price and trading
- Previous close
- 2.46
- Open
- 2.43
- Day range
- 2.12 – 2.53
- 52-week range
- 2.12 – 11.15
- 52-week change
- -77.78%
- Beta
- —
- Volume
- 760.37K
- Average volume
- 271.05K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 20.03M
- Forward Pe
- -0.44
- Eps
- -7.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.15
- Week52 Low
- 2.12
- Avg Volume
- 271.05K
- Shares Outstanding
- 9.36M
- Ma50
- 5.23
- Ma200
- 7.30
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -80.81%
- Pct From52w Low
- 0.94%